News
Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International ConferenceCompany’s first development candidate in autoimmune and inflammatory disease (AIID) demonstrates ...
Company's first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammationNovel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback